Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 507.20
Change Today 0.00 / 0.00%
Volume 0.0
RDHL On Other Exchanges
As of 10:24 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gilead Raday MPhil, MSc

Senior Vice President of Corporate & Product Development,RedHill Biopharma Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 1 different organizations across 4 different industries.

As of Fiscal Year 2014


Mr. Gilead Raday, MPhil, MSc, has been Senior Vice President of Corporate & Product Development at RedHill Biopharma Ltd. since December 5, 2012. Mr. Raday is a principal of CSS Capital Managers LLP, or CSS, an affiliate of Charles Street Securities Europe LLP, or CSS Europe. He partly owns manages the Bio-Pharma financing practice of CSS Europe in Israel. He served as Vice President of Corporate and Product Development at RedHill Biopharma Ltd. from November 2010 to ...

Read Full Background

Corporate Headquarters*

21 Ha’arba’a Street
Tel Aviv, -- 64739


Phone: 972 3 541 3131
Fax: 972 3 541 3144

Board Members Memberships*



Master's Degree 2004
University of Cambridge
MS 2007
Hebrew University of Jerusalem
Hebrew University of Jerusalem

Other Affiliations*

Annual Compensation*

Total Annual Compensation$216,000

Stock Options*

Restricted Stock Awards$137,859
All Other Compensation$17,286

Total Compensation*

Total Annual Cash Compensation$233,286
Total Short Term Compensation$216,000
Other Long Term Compensation$155,145
Total Calculated Compensation$371,145
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RDHL:IT 507.20 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REDHILL BIOPHARMA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at